LGALS3BP and cancer: Furthermore, previous studies have reported that cancer patients with Mac-2BP over-expressing tumors are more likely to develop distant metastasis, have shorter disease free survival, and have adverse prognosis compared to patients with low Mac-2BP expressing tumors [31], [51].